Editorial: real ‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease—Author's reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 227-227, July 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: S. L. Flamm Source Type: research
More News: Drugs & Pharmacology | Urology & Nephrology